KALA BIO, INC. Gain (Loss) on Disposition of Assets
KALA BIO, INC. (KALA) reported Gain (Loss) on Disposition of Assets of -$9.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2019-11-07
- KALA BIO, INC. gain (loss) on disposition of assets for the quarter ending 2018-09-30 was -$5.00K.
- KALA BIO, INC. gain (loss) on disposition of assets for the quarter ending 2018-06-30 was $0.00.
- KALA BIO, INC. gain (loss) on disposition of assets for the quarter ending 2018-03-31 was -$4.00K.
- KALA BIO, INC. gain (loss) on disposition of assets for fiscal 2015 was -$19.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2018-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$5.00K derived: sum of 2 quarters · filed 2019-11-07 | -$9.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$4.00K 10-Q · filed 2018-08-09 | ||
| 2018-03-31 | -$4.00K 10-Q · filed 2018-05-10 | |||
| 2015-12-31 | -$19.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |